Evidence map›Paper›PMID 38734511›Full record

ArticleResearch in social & administrative pharmacy : RSAP2024

ASAP: A pharmacy-level intervention to increase nonprescription syringe sales to reduce bloodborne illnesses.

B E Meyerson, J Agley, R A Crosby, K G Bentele, N Vadiei, L B Linde-Krieger, D R Russell, K Fine, L A Eldridge

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Research in social & administrative pharmacy : RSAP, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

B E MeyersonHarm Reduction Research Lab, Department of Family and Community Medicine, College of Medicine-Tucson, Tucson, University of Arizona, USA; Comprehensive Center for Pain and Addiction, University of Arizona Health Sciences, Tucson, AZ, USA. Electronic address: bmeyerson@arizona.edu.
J AgleyHarm Reduction Research Lab, Department of Family and Community Medicine, College of Medicine-Tucson, Tucson, University of Arizona, USA; Indiana University School of Public Health-Bloomington, Bloomington, IN, USA.
R A CrosbyHarm Reduction Research Lab, Department of Family and Community Medicine, College of Medicine-Tucson, Tucson, University of Arizona, USA; College of Public Health, University of Kentucky, Lexington, KY, USA.
K G BenteleHarm Reduction Research Lab, Department of Family and Community Medicine, College of Medicine-Tucson, Tucson, University of Arizona, USA; Southwest Institute for Research on Women, College of Social and Behavioral Sciences, University of Arizona, Tucson, AZ, USA.
N VadieiHarm Reduction Research Lab, Department of Family and Community Medicine, College of Medicine-Tucson, Tucson, University of Arizona, USA; Pharmacotherapy Division, University of Texas at Austin, Austin, TX, USA.
L B Linde-KriegerHarm Reduction Research Lab, Department of Family and Community Medicine, College of Medicine-Tucson, Tucson, University of Arizona, USA; Comprehensive Center for Pain and Addiction, University of Arizona Health Sciences, Tucson, AZ, USA.
D R RussellHarm Reduction Research Lab, Department of Family and Community Medicine, College of Medicine-Tucson, Tucson, University of Arizona, USA; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
K FineArizona Pharmacy Association, Phoenix, AZ, USA.
L A EldridgeHarm Reduction Research Lab, Department of Family and Community Medicine, College of Medicine-Tucson, Tucson, University of Arizona, USA; Department of Health Education and Promotion, College of Health and Human Performance, East Carolina University, Greenville, NC, USA.

Funding

ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections among People who Inject DrugsR03DA053252 · NIDA · UNIVERSITY OF ARIZONA · PI MEYERSON, BETH · 2021 to 2022
$154k
NIDA NIH HHS R03 DA053252
6 · The paper itself

Abstract

backgroundPharmacy syringe sales are effective structural interventions to reduce bloodborne illnesses in populations, and are legal in all but two states. Yet evidence indicates reduced syringe sales in recent years. This study was designed as a feasibility test of an intervention to promote syringe sales by pharmacies in Arizona.

methodsA four-month pilot among three Arizona pharmacies measured feasibility and acceptability through monthly surveys to 18 enrolled pharmacy staff members.

resultsPharmacy staff reported increased ease of dispensing syringes across the study. Rankings of syringe dispensing as 'easiest' among 6 measured pharmacy practices increased from 38.9 % at baseline to 50.1 % post intervention module training, and to 83.3 % at pilot conclusion. The majority (72.2 %) of pharmacy staff agreed that intervention materials were easy to use. Over 70 % indicated that the intervention was influential in their "being more open to selling syringes without a prescription to someone who might use them for illicit drug use," and 61.1 % reported that in the future, they were highly likely to dispense syringes to customers who would use them to inject drugs. A vast majority (92 %) reported being likely to dispense subsidized naloxone if available to their pharmacy at no cost.

conclusionsAn education-based intervention was found to be feasible and acceptable to pharmacy staff and had an observed impact on perceptions of ease and likelihood of dispensing syringes without a prescription to people who may use them to inject drugs.

Indexed as

SyringesArizonaBlood-Borne PathogensCommerceCommunity Pharmacy ServicesFeasibility StudiesHumansNaloxoneNarcotic AntagonistsPharmaciesPharmacistsPilot ProjectsNaloxoneNarcotic AntagonistsHarm reductionImplementation sciencePharmacy practiceSyringe access

Identifiers

PMID38734511
PMCPMC11180557

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.